News ArticleTata Consultancy Services 2026 Study Finds 84% of Executives Cite Productivity as AI's Top Benefit Amid Security Concerns
Only 10% of global enterprises allow AI agents full autonomy, with security and governance leading deployment decisions across 25 countries
Tata Consultancy Services' 2026 global enterprise AI study highlights that 84% of executives cite productivity as the main AI benefit, yet only 10% permit AI autonomous decision-making, emphasizing security and governance as key factors shaping AI deployment strategies.
Tata Consultancy Services Limited
General / Other
Tata Consultancy Services released its 2026 global Enterprise AI Study revealing that 84% of surveyed executives rank productivity improvement as the top benefit of AI, but only 10% allow AI agents to make decisions autonomously without human oversight, underscoring security, risk, and governance as primary considerations in AI deployment.
The study surveyed 1,333 senior business and technology leaders across 25 countries and 12 industries, highlighting a strong emphasis on security and governance over cost and speed when deploying AI systems.
Only 9% of executives report that AI agents can securely orchestrate workflows across enterprise applications, indicating limited operational autonomy for AI despite recognized benefits.
Human+AI operating models are evolving, with organizations balancing AI autonomy with necessary human oversight to manage risks effectively.
Regional differences show North America leading in treating AI as a strategic enterprise capability, Europe focusing on AI sovereignty concerns, and the UK and Ireland excelling in AI continuity planning and governance integration.
Other findings include ongoing reviews of AI economics, fragmented enterprise knowledge limiting AI context access, adoption of open-source AI in 46% of cases, and increasing uncertainty about AI's workforce impact.
Highlights
- 84% of global executives identify productivity improvement as AI's leading value from investments.
- Only 10% of enterprises allow AI agents to make decisions without human approval.
- Security, risk, and governance rank as the top factors influencing AI deployment, surpassing cost and speed.
- Just 9% report AI-capable secure orchestration across enterprise applications.
- 90% emphasize model independence in AI investments; 34% perceive AI sovereignty as a high organizational risk.
- Regional differences include North America's strategic AI focus and Europe's heightened AI sovereignty concerns.
Key Data Snapshot
What happened
- TCS published a global study on enterprise AI adoption and impact involving 1,333 senior executives.
- The study highlights productivity as the leading AI benefit and security as the foremost concern in AI implementation.
- Current enterprise AI deployment allows limited autonomous AI decisions, emphasizing human oversight.
- The study reveals regional variations in AI adoption focus and readiness, including sovereignty and resilience priorities.
Key details
- 84% of executives rank productivity improvement as AI's top benefit.
- Only 10% of organizations permit AI to act without human approval across multiple functions.
- Security, risk, and governance are prioritized over cost and speed for AI deployment.
- 90% emphasize AI model independence; 34% perceive high risk related to AI sovereignty, especially in Europe (43%).
- Only 7% have organization-wide AI provider-switching continuity plans.
- 44% report enterprise knowledge fragmentation, limiting AI's access to business context.
- 46% deploy open-source AI in targeted use cases.
- AI's effect on jobs is increasingly uncertain, with 19% stating it's too early to determine in 2026.
Strategic context
- Enterprise AI is transitioning toward a Human+AI operating model balancing autonomy and oversight.
- Security and governance are key to expanding AI's autonomous capabilities responsibly.
- Regional differences influence AI priorities: North America leads strategic adoption, Europe focuses on sovereignty, UK and Ireland excel in resilience planning.
Background and context
- TCS is a global IT services and consulting company with revenues over US $30 billion in fiscal year ended March 31, 2026.
- The company aims to be the largest AI-led technology services firm, enabling client transformation across AI infrastructure and intelligence.
- TCS has a presence in 56 countries and 194 service delivery centers worldwide.
Highlights
- 84% of global executives identify productivity improvement as AI's leading value from investments.
- Only 10% of enterprises allow AI agents to make decisions without human approval.
- Security, risk, and governance rank as the top factors influencing AI deployment, surpassing cost and speed.
- Just 9% report AI-capable secure orchestration across enterprise applications.
- 90% emphasize model independence in AI investments; 34% perceive AI sovereignty as a high organizational risk.
- Regional differences include North America's strategic AI focus and Europe's heightened AI sovereignty concerns.
Disclosures
- BSE Listing Regulations
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Biocon Limited Reports Q2 FY2027 Profit of Rs. 917 Million and Announces New CTO Appointment
Biocon Limited disclosed its unaudited standalone financial results for the quarter and half year ending September 30, 2026, with a quarterly profit of Rs. 917 million. The board also approved the resignation of CTO Dr. Mandar Shrikant Ghatnekar effective December 31, 2026, and the appointment of Mr. Mukesh Rathi as CTO starting January 1, 2027.
Read Full Story
Biocon Reports Q2 FY27 Total Income of Rs 4,423 Crore With Biopharma Revenue Up 5% and $400 Million Pertuzumab Deal
Biocon Limited announced consolidated total income of Rs 4,423 crore for the second quarter of fiscal year 2027, with biopharma revenues increasing by 5% year-on-year to Rs 3,583 crore. The company's EBITDA was reported at Rs 865 crore and net profit at Rs 41 crore. A significant highlight includes securing a 10-year biosimilar Pertuzumab PDP partnership in Brazil valued at about USD 400 million.
Read Full Story
Zydus Lifesciences Posts Rs. 79,096 Million Revenue in Q2 FY27 with Net Profit at Rs. 9,255 Million
Zydus Lifesciences Limited reported strong revenue growth of 29% year-on-year in Q2 FY27 at Rs. 79,096 million, driven by its branded pharma businesses in India, North America, and international markets. However, net profit declined 27% to Rs. 9,255 million, and EBITDA dropped 6% to Rs. 18,945 million, reflecting cost and margin pressures.
Read Full Story
